Skip to main content
BBBL logo
BBBL
(NYSEARCA)
BondBloxx BBB Rated 10+ Year Corporate Bond ETF
$45.73-- (--)
Loading... - Market loading

BBBL ETF: BondBloxx BBB Rated 10+ Year Corporate Bond ETF - Price, Holdings & Analysis

BondBloxx BBB Rated 10+ Year Corporate Bond ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$45.73 - $45.73
52-Week High$50.54
52-Week Low$45.54
Open$45.73
Volume100
Average Volume (3M)1.07K
Assets (AUM)9.26M
Expense Ratio0.19%
Total Holdings883
Inception DateJan 25, 2024
1 Day Change0.18%
1 Month Change-1.30%
6 Month Change-5.77%
YTD Change-5.26%
1 Year Change-6.97%
52-Week Change-6.97%
50-Day MA$46.45
200-Day MA$47.78
RSI42.55
Stochastic %K14.88
Stochastic %D11.77
Annual Dividend$2.46
Dividend Yield5.38%
Last Dividend Ex-DateSep 1, 2026
Dividend Growth YoY-11.60%
Years Dividend Growth1

Frequently Asked Questions About BondBloxx BBB Rated 10+ Year Corporate Bond ETF

What is the current price of BBBL?

The latest BBBL price is $45.73. The 52-week range is $45.54–$50.54. BBBL has returned -7.0% over the past 52 weeks.

What is the expense ratio for BBBL?

BBBL's annual expense ratio is 0.19%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Fixed Income ETFs in the ETF Screener.

Does BBBL pay dividends?

Yes, BBBL pays a 5.38% dividend yield. The last ex-dividend date was 2026-09-01. View full dividend history in the Dividends section.

What are the top holdings of BBBL?

BBBL's largest holdings are CVS Health Corp 5.05% (0.8%), Goldman Sachs Group, Inc. 6.75% (0.7%), Boeing Co. 5.81% (0.6%) (combined weight: 2.2%). The fund holds 883 total positions. View the complete portfolio breakdown in the Holdings section.

How does BBBL compare to similar ETFs?

Compare BBBL (0.19% expense ratio, $9M AUM) against similar Fixed Income ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.